F. Figoli

发表

Carcinoembryonic Antigen (CEA) in the Follow-Up of Disease-Free Breast Cancer Patients

R. Talamini, D. Crivellari, V. Zagonel, 1982, Tumori.

1064 Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study

L. Crinò, M. Marangolo, V. Adamo, 1995 .

Non-Hodgkin’s Lymphomas in Patients with AIDS

F. Lombardi, P. Cazzaniga, S. Pileri, 1990 .

Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).

L. Crinò, C. Boni, M. Clerici, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Impact of intensity and timing of integrated home palliative cancer care on end-of-life hospitalization in Northern Italy

M. Pellizzari, F. Avossa, E. Ferroni, 2017, Supportive Care in Cancer.

Epidemic Kaposi's sarcoma in female AIDS patients--a report of 23 Italian cases.

U. Tirelli, D. Greco, F. Figoli, 1991, AIDS (London).

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.

G. Scagliotti, F. de Marinis, L. Crinò, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cisplatin (CDDP)-etoposide VS DCCP-mitomycin-vindesine VS CDDP-mitomycin-iphosphamide in advanced non small cell lung cancer (NSCLC). A prospective randomized trial of the Italian oncology group for clinical research. (GOIRC)

L. Crinò, C. Boni, M. Clerici, 1993 .

Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effusion

R. Urso, S. Monfardini, M. D’Incalci, 2004, Cancer Chemotherapy and Pharmacology.

End-of-Life Place of Care, Health Care Settings, and Health Care Transitions Among Cancer Patients: Impact of an Integrated Cancer Palliative Care Plan.

U. Fedeli, F. Avossa, E. Ferroni, 2017, Journal of pain and symptom management.

[Bilateral nodular pulmonary histoplasmosis: cytohistological correlation].

A. Armani, A. Vaglia, S. Dante, 1991, Pathologica.

Randomized crossover antiemetic study in cisplatin-treated patients

D. Crivellari, U. Tirelli, E. Galligioni, 1986, Cancer Chemotherapy and Pharmacology.

Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group.

G. Luporini, A. Rossi, C. Gridelli, 1999, Journal of the National Cancer Institute.

Neoplastic infiltration of the myocardium: in vivo diagnosis and follow-up by two-dimensional echocardiography

E. Galligioni, G. Nicolosi, D. Zanuttini, 1985 .

Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

R. Labianca, V. Torri, A. Piga, 2008, Journal of the National Cancer Institute.

Leucovorin calcium enhancement of mucositis after continuous infusion fluorouracil and short infusion cisplatin.

V. Chiarion Sileni, V. Fosser, M. Gulisano, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancer

R. Talamini, S. Monfardini, V. Zagonel, 2004, Cancer Chemotherapy and Pharmacology.

Cisplatin and etoposide as second-line chemotherapy in patients with small cell lung cancer.

A. Ardizzoni, S. Monfardini, V. Zagonel, 1988, Cancer investigation.

Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer

G. Scagliotti, L. Crinò, M. Marangolo, 1996, Cancer Chemotherapy and Pharmacology.

Cisplatin and 5-fluorouracil combination chemotherapy in advanced and/or metastatic colorectal carcinoma: a phase II study.

D. Crivellari, E. Vaccher, G. Gasparini, 1987, European journal of cancer & clinical oncology.

Pharmacokinetics of 7-con-O-methylnogarol in patients with solid tumors

S. Monfardini, M. D’Incalci, U. Tirelli, 2004, Cancer Chemotherapy and Pharmacology.

Combination chemotherapy with adriamycin and 5-fluorouracil in advanced bladder carcinoma.

U. Tirelli, M. Trovò, E. Galligioni, 1982, Clinical oncology.

High-dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research.

C. Boni, F. di Costanzo, R. Passalacqua, 1998, American journal of clinical oncology.

Evaluation of two consecutive regimens in advanced gastric cancer.

R. Talamini, D. Crivellari, S. Monfardini, 1991, Cancer investigation.

Phase II Study of Five‐Day Continuous Infusion of Vinblastine in Patients With Metastatic Renal‐Cell Carcinoma

D. Crivellari, S. Monfardini, E. Galligioni, 1987, American journal of clinical oncology.

Chlorozotocin treatment of advanced gastrointestinal cancer.

V. Zagonel, U. Tirelli, E. Galligioni, 1983, Medical and Pediatric Oncology.

Preliminary report of high dose folinic acid and 5‐fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: A randomized trial of the italian oncology group for clinical research

F. Costanzo, R. Passalacqua, S. Zironi, 1991, Journal of surgical oncology. Supplement.

Intensity of integrated cancer palliative care plans and end‐of‐life acute medical hospitalisation among cancer patient in Northern Italy

M. Pellizzari, U. Fedeli, F. Avossa, 2018, European journal of cancer care.

Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).

L. Crinò, M. Clerici, M. Tonato, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the Italian Oncology Group for Clinical Research.

L. Crinò, M. Clerici, F. di Costanzo, 1995, Lung Cancer.